Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 8

    1.

    Ultrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection.

    Fiscus SA, Wiener J, Abrams EJ, Bulterys M, Cachafeiro A, Respess RA.

    J Clin Microbiol. 2007 Jul;45(7):2274-7. Epub 2007 May 2.PMID: 17475763 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    HIV-1 viral load assays for resource-limited settings.

    Fiscus SA, Cheng B, Crowe SM, Demeter L, Jennings C, Miller V, Respess R, Stevens W; Forum for Collaborative HIV Research Alternative Viral Load Assay Working Group.

    PLoS Med. 2006 Oct;3(10):e417. Review. No abstract available. PMID: 17032062 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay.

    Jennings C, Fiscus SA, Crowe SM, Danilovic AD, Morack RJ, Scianna S, Cachafeiro A, Brambilla DJ, Schupbach J, Stevens W, Respess R, Varnier OE, Corrigan GE, Gronowitz JS, Ussery MA, Bremer JW.

    J Clin Microbiol. 2005 Dec;43(12):5950-6.PMID: 16333081 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings.

    Respess RA, Cachafeiro A, Withum D, Fiscus SA, Newman D, Branson B, Varnier OE, Lewis K, Dondero TJ.

    J Clin Microbiol. 2005 Jan;43(1):506-8.PMID: 15635029 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Antiretroviral drug resistance in human immunodeficiency virus-infected source patients for occupational exposures to healthcare workers.

    Beltrami EM, Cheingsong R, Heneine WM, Respess RA, Orelien JG, Mendelson MH, Stewart MA, Koll BS, Sulis CA, Cardo DM; Occupational HIV Exposure Study Group.

    Infect Control Hosp Epidemiol. 2003 Oct;24(10):724-30.PMID: 14587931 [PubMed - indexed for MEDLINE]Related articles

    6.

    Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative--Uganda.

    Weidle PJ, Downing R, Sozi C, Mwebaze R, Rukundo G, Malamba S, Respess R, Hertogs K, Larder B, Ochola D, Mermin J, Samb B, Lackritz E.

    AIDS. 2003 Jul;17 Suppl 3:S39-48.PMID: 14565608 [PubMed - indexed for MEDLINE]Related articles

    7.

    Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa.

    Gottlieb GS, Sow PS, Hawes SE, Ndoye I, Redman M, Coll-Seck AM, Faye-Niang MA, Diop A, Kuypers JM, Critchlow CW, Respess R, Mullins JI, Kiviat NB.

    J Infect Dis. 2002 Apr 1;185(7):905-14. Epub 2002 Mar 19.PMID: 11920314 [PubMed - indexed for MEDLINE]Related articles

    8.

    Comparative analysis of two commercial phenotypic assays for drug susceptibility testing of human immunodeficiency virus type 1.

    Qari SH, Respess R, Weinstock H, Beltrami EM, Hertogs K, Larder BA, Petropoulos CJ, Hellmann N, Heneine W.

    J Clin Microbiol. 2002 Jan;40(1):31-5.PMID: 11773089 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...